4 months ago
NBIX
AnalystsCarter GouldCarter Gould's Stock Forecasts
AnalystsCarter Gould
Analyst Ranking
Top 16%
#758 out of 4861 analysts
Average Return
+4.15%
Win Rate
48%56 out of 117
Risk vs Reward
Poor
Good
Carter Gould's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Reata Pharmaceuticals IncRETA | +334.02% | $38.27 | $166.10 | 2022-11-09 - 2023-08-01 | Strong Buy |
Skillsoft CorpSKIL | +290.64% | $5.45 | $21.29 | 2024-04-16 - 2025-04-15 | Strong Buy |
Travere Therapeutics IncTVTX | +93.76% | $7.85 | $15.21 | 2023-09-22 - 2024-09-20 | Strong Buy |
Eli Lilly & CoLLY | +92.48% | $405.81 | $781.10 | 2023-05-01 - 2024-04-30 | Strong Buy |
Reata Pharmaceuticals IncRETA | +88.73% | $88.01 | $166.10 | 2023-05-11 - 2023-08-01 | Strong Buy |
Carter Gould Analyst Color
Get additional color on Carter Gould's coverage of popular stocks
6 months ago
TVTX
6 months ago
LLY
6 months ago
ABBV
7 months ago
TVTX
9 months ago
REGN
9 months ago
NBIX
9 months ago
ABBV
9 months ago
LLY
9 months ago
PFE
9 months ago
REGN
10 months ago
GERN
a year ago
ABBV
a year ago
LLY
a year ago
ABBV
a year ago
REGN
a year ago
NBIX
a year ago
LLY
a year ago
ABBV
a year ago
PFE
a year ago
PFE
a year ago
ABBV
2 years ago
LLY
2 years ago
PFE
2 years ago
PFE
Carter Gould's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Neurocrine Biosciences IncNBIX | 11 | Strong Buy | $165.00 | +62.75% | Maintains | 4 months ago |
Gilead Sciences IncGILD | 13 | Hold | $95.00 | -9.13% | Maintains | 5 months ago |
Regeneron Pharmaceuticals IncREGN | 14 | Strong Buy | $1,065.00 | +89.11% | Maintains | 6 months ago |
Travere Therapeutics IncTVTX | 6 | Strong Buy | $20.00 | +34.05% | Maintains | 6 months ago |
Eli Lilly & CoLLY | 11 | Strong Buy | $975.00 | +16.08% | Maintains | 6 months ago |
Biogen IncBIIB | 21 | Hold | $180.00 | +51.76% | Maintains | 6 months ago |
Bristol Myers Squibb CoBMY | 14 | Strong Sell | $43.00 | -12.65% | Maintains | 6 months ago |
Merck & Co IncMRK | 10 | Strong Buy | $140.00 | +79.49% | Maintains | 6 months ago |
Amgen IncAMGN | 14 | Hold | $315.00 | +13.60% | Maintains | 6 months ago |
Abbvie IncABBV | 14 | Strong Buy | $212.00 | +22.55% | Maintains | 6 months ago |
Nuvalent IncNUVL | 1 | Strong Buy | $100.00 | +39.59% | Initiates Coverage On | 8 months ago |
Vor Biopharma IncVOR | 3 | Strong Buy | $3.00 | +361.54% | Maintains | 8 months ago |
Pfizer IncPFE | 13 | Hold | $32.00 | +44.53% | Maintains | 9 months ago |
Barinthus Biotherapeutics PLCBRNS | 1 | Strong Buy | $3.00 | +310.96% | Maintains | 10 months ago |
Geron CorpGERN | 1 | Strong Buy | $9.00 | +608.66% | Initiates Coverage On | 10 months ago |
Cytokinetics IncCYTK | 2 | Strong Buy | $95.00 | +140.63% | Maintains | a year ago |
Skillsoft CorpSKIL | 5 | Strong Buy | $20.00 | N/A | Maintains | a year ago |
Arcellx IncACLX | 4 | Strong Buy | $73.00 | N/A | Maintains | a year ago |
Allakos IncALLK | 4 | Strong Sell | $1.00 | N/A | Maintains | a year ago |
Reata Pharmaceuticals IncRETA | 7 | Hold | $172.00 | N/A | Downgrades | 2 years ago |
Alector IncALEC | 2 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Gossamer Bio IncGOSS | 5 | Hold | $1.50 | N/A | Maintains | 2 years ago |
Molecular Templates IncMTEM | 3 | Strong Buy | $15.00 | N/A | Maintains | 2 years ago |
Applied Therapeutics IncAPLT | 4 | Hold | $2.25 | N/A | Maintains | 3 years ago |
Paycom Software IncPAYC | 1 | Hold | $380.00 | N/A | Maintains | 3 years ago |
Acceleron Pharma IncXLRN | 3 | Hold | $180.00 | N/A | Downgrades | 4 years ago |
Celgene CorpCELG | 3 | Hold | N/A | N/A | Downgrades | 6 years ago |
Incyte CorpINCY | 3 | Hold | $82.00 | N/A | Downgrades | 6 years ago |
Vertex Pharmaceuticals IncVRTX | 1 | Hold | $188.00 | N/A | Maintains | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.